<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The B cell response to ligation of surface immunoglobulin (sIg) and CD40 is dependent on the stage of cellular differentiation of the population studied </plain></SENT>
<SENT sid="1" pm="."><plain>Cross-linking sIg promotes proliferation of follicular mantle (FM) B cells, rescues germinal center (GC) B cells from spontaneous <z:mpath ids='MPATH_3'>apoptosis</z:mpath> but induces <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in susceptible Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) B cells; signals transduced through CD40 induce resting FM B cells to enter cell cycle while promoting GC and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> B cell survival </plain></SENT>
<SENT sid="2" pm="."><plain>This study investigates whether the 3', 5'-cyclic <z:chebi fb="3" ids="16335">adenosine</z:chebi> monophosphate (cAMP)-dependent second-messenger pathway plays a role in the regulation of these sIg- and CD40-promoted B cell responses, using <z:chebi fb="0" ids="15551">prostaglandin E2</z:chebi> (<z:chebi fb="0" ids="15551">PGE2</z:chebi>) and <z:chebi fb="0" ids="42471">forskolin</z:chebi> to artificially increase intracellular levels of cAMP </plain></SENT>
<SENT sid="3" pm="."><plain>The Epstein-Barr virus (EBV)-genome-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> B cell line Ramos is susceptible to <z:mpath ids='MPATH_73'>growth arrest</z:mpath> and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> triggered by <z:chebi fb="0" ids="22986">calcium ionophore</z:chebi>, anti-IgM and <z:chebi fb="0" ids="42471">forskolin</z:chebi> but not by <z:chebi fb="0" ids="15551">PGE2</z:chebi>; <z:chebi fb="0" ids="42471">forskolin</z:chebi> does not affect the outcome of anti-IgM treatment </plain></SENT>
<SENT sid="4" pm="."><plain>Anti-CD40 rescues Ramos-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> B cells from <z:chebi fb="0" ids="24869">ionophore</z:chebi>- and anti-IgM-triggered but not <z:chebi fb="0" ids="42471">forskolin</z:chebi>-triggered <z:mpath ids='MPATH_73'>growth arrest</z:mpath> and <z:mpath ids='MPATH_3'>apoptosis</z:mpath>; moreover, <z:chebi fb="0" ids="42471">forskolin</z:chebi> and anti-CD40 act additively and independently for enhanced growth inhibition </plain></SENT>
<SENT sid="5" pm="."><plain>By contrast, both <z:chebi fb="0" ids="42471">forskolin</z:chebi> and <z:chebi fb="0" ids="15551">PGE2</z:chebi> potentiate the proliferative response of FM B cells cultured with anti-Ig and anti-CD40 together but not individually </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="42471">Forskolin</z:chebi> and <z:chebi fb="0" ids="15551">PGE2</z:chebi> fail to affect the spontaneous <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and anti-Ig- and anti-CD40-promoted survival of GC B cells </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, the cAMP-dependent second messenger pathway can differentially influence the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>, FM, and GC B cell functional response to signals transduced through sIg and CD40 </plain></SENT>
</text></document>